Yong Yang
Impact in
- Cancer Research top 2%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Pharmacology top 1%
- Flavonoids in Medical Research
Papers in
- Pharmacology 26
- Flavonoids in Medical Research 13
- Synthesis of Organic Compounds 10
-
- Protein Degradation and Inhibitors 6
- Co-authors
- Qinglong Guo (31 shared papers)Qi-Dong You (31 shared papers)Na Lu (23 shared papers)Qiuhua Cao (10 shared papers)Xinghua Gao (10 shared papers)Hong-Yan Gu (19 shared papers)Xian-Jing Li (20 shared papers)Qi Qi (21 shared papers)
- Journals
- Cancer Letters (10 papers)European Journal of Pharmacology (7 papers)Cell Death and Disease (4 papers)Journal of Controlled Release (3 papers)PLoS ONE (3 papers)
- Partner nations
- ChinaUnited StatesSingapore
In The Last Decade
Yong Yang
130 papers receiving 6.8k citations
Yong Yang's Hit Papers
Peers
Comparison fields: 5 of 133
- Cancer Research 1.1k
- Pharmacology 928
- Biochemistry 420
- Molecular Biology 3.1k
- Biological Psychiatry 95
Countries citing papers authored by Yong Yang
This map shows the geographic impact of Yong Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yong Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yong Yang more than expected).
Fields of papers citing papers by Yong Yang
This network shows the impact of papers produced by Yong Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yong Yang. The network helps show where Yong Yang may publish in the future.
Co-authors
The 25 scholars most cited alongside Yong Yang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 132 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Quercetin alleviates acute kidney injury by inhibiting ferroptosis Hit paper breakdown → | 2020 | 499 |
| 2 | 2018 | 367 | |
| 3 | ACSL4 deficiency confers protection against ferroptosis-mediated acute kidney injury Hit paper breakdown → | 2022 | 346 |
| 4 | Chronic stress promotes colitis by disturbing the gut microbiota and triggering immune system response Hit paper breakdown → | 2018 | 319 |
| 5 | 2018 | 246 | |
| 6 | 2007 | 216 | |
| 7 | 2010 | 181 | |
| 8 | 2009 | 179 | |
| 9 | 2020 | 178 | |
| 10 | 2007 | 155 | |
| 11 | 2015 | 132 | |
| 12 | 2007 | 128 | |
| 13 | 2018 | 112 | |
| 14 | 2020 | 99 | |
| 15 | 2020 | 98 | |
| 16 | 2020 | 97 | |
| 17 | 2007 | 91 | |
| 18 | 2008 | 88 | |
| 19 | 2021 | 88 | |
| 20 | 2021 | 86 |
About Yong Yang
Yong Yang is a scholar working on Pharmacology, Molecular Biology, Immunology, Oncology and Cancer Research, having authored 132 papers that have together received 6.9k indexed citations. Recurring topics across this work include Flavonoids in Medical Research (13 papers), Natural Compound Pharmacology Studies (11 papers), Synthesis of Organic Compounds (10 papers), Protein Degradation and Inhibitors (6 papers), Cancer, Lipids, and Metabolism (6 papers), Prostate Cancer Treatment and Research (6 papers), CAR-T cell therapy research (5 papers) and Cancer-related Molecular Pathways (5 papers). The work is most often cited by research in Cancer Research (1.1k citations), Pharmacology (928 citations), Biochemistry (420 citations), Molecular Biology (3.1k citations) and Biological Psychiatry (95 citations). Yong Yang has collaborated with scholars based in China, United States and Singapore. Frequent co-authors include Qinglong Guo, Qi-Dong You, Na Lu, Qiuhua Cao, Xinghua Gao, Hong-Yan Gu, Xian-Jing Li, Qi Qi, Hongbao Yang and Jin‐Song Bian. Their work appears in journals such as Cancer Letters, European Journal of Pharmacology, Cell Death and Disease, Journal of Controlled Release and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.